Authors: Vera E. Bukkems, Teun M. Post, Angela P. Colbers, David M. Burger, Elin M. Svensson Published in: American Society for Clinical Pharmacology and Therapeutics Abstract: Once‐daily two 600mg tablets…
Authors: Bollen P, Freriksen J, Konopnicki D, Weizsäcker K , et al; on behalf of the Pharmacokinetics of ANtiretroviral agents in HIV-infected pregNAnt women Network Published in: Clin infect Dis. 2020;26.ciaa006…
Authors: Bukkems V, Necsoi C, Hidalgo Tenorio C, et al. PANNA Network Published in: Clin infect Dis. 2020; 24;ciaa488. Abstract This phase-IV study investigated the influence of pregnancy on the pharmacokinetics…
Authors: Colbers A, Bollen P, Freriksen J, Konopnicki D, Weizsäcker K, Hidalgo Tenorio C, Moltó J, Taylor G, Alejandre I, van Crevel R, Burger D; on behalf of the PANNA…
Authors: Colbers A, Bollen P, Freriksen J, Konopnicki D, Weizsäcker K, Hidalgo Tenorio C, Moltó J, Taylor G, Alejandre I, van Crevel R, Burger D. Published: Oral presentation at 9th…
Authors: Kreitchmann R, Schalkwijk S, Best B, et al. Published in: Antivir Ther. 2019;24(2):95-103 Background Limited data exist on efavirenz pharmacokinetics in HIV-positive pregnant women and neonatal washout. Methods HIV-infected pregnant women receiving…
Authors: Schalkwijk S, Ter Heine R, Colbers A, et al. Published in: J Antimicrob Chemother. 2019;30 [Epub ahead of print] Background Darunavir 800 mg once (q24h) or 600 mg twice (q12h) daily…
Authors: Bollen P, Colbers A, Schalkwijk S, Velthoven-Graafland K, Konopnicki D, Weizsacker K, Hidalgo Tenorio C, van Crevel R, Burger D, on behalf of the PANNA network Published: Oral presentation…
Authors: Colbers A, Schalkwijk S, Konopnicki D, Rockstroh J, Burger D, on behalf of the PANNA network Published: Oral presentation at 19th edition of the International Workshop on Clinical Pharmacology…
Authors: Schalkwijk S, Colbers A, Konopnicki D, et al. Published in: Clin Infect Dis. 2017; 65(8):1335-1341. Background The use of antiretroviral therapy during pregnancy is important for control of maternal…
Authors: Colbers A, Schalkwijk S, Konopnicki D, Gingelmaier A, Lambert J, van der Ende I, Moltó J, Burger D. Published: 24th Conference on Retroviruses and Opportunistic Infections, February 13th –…
Authors: Colbers A, Best B, Schalkwijk S, et al. PANNA Network and the IMPAACT 1026 Study Team. Published in: Clin Pharmacokinet. 2016;55(3):381-96 Abstract Pregnant women are usually excluded from clinical trials.…
Authors: Schalkwijk S, ter Heine R, Colbers A, Huitema A, Denti P, Dooley K, Capparelli E, Best B, Cressey T, Greupink R, Russel F, Mirochnick M, Burger D. Published: 17th…
Authors: Colbers A, Schalkwijk S, Konopnicki D, Hawkins D, Hidalgo Tenorio C, Moltò J, Taylor G, Weizsacker K, van der Ende M, Burger D Published: Oral presentation at 17th edition…
Authors: Schalkwijk S, Best B, Colbers A, SteK A, Wang J, Hawkins D, Mirochnick M, Burger D; for the The International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1026s Protocol…
Authors: Blonk MI, Colbers AP, HidalgoTenorio C, et al. Published in: Front Pharmacol. 2016 Aug 4;7:239. Background: The study goal was to describe etravirine pharmacokinetics during pregnancy and postpartum in HIV-infected women. Methods: IMPAACT…
Authors: Schalkwijk S, Colbers A, Konopnicki D, et al. For PANNA network Published in: AIDS. 2016;30(8):1239-44. Objective To describe the pharmacokinetics of abacavir 600 mg once daily (q.d.) in HIV-1-positive women during pregnancy and…